Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000950170-25-028356
Filing Date
2025-02-27
Accepted
2025-02-27 07:20:24
Documents
88
Period of Report
2024-12-31

Document Format Files

Seq Description Document Type Size
1 10-K dyn-20241231.htm   iXBRL 10-K 3461202
2 EX-19.1 dyn-ex19_1.htm EX-19.1 93847
3 EX-21.1 dyn-ex21_1.htm EX-21.1 5758
4 EX-23.1 dyn-ex23_1.htm EX-23.1 4839
5 EX-31.1 dyn-ex31_1.htm EX-31.1 12497
6 EX-31.2 dyn-ex31_2.htm EX-31.2 12165
7 EX-32.1 dyn-ex32_1.htm EX-32.1 6453
8 EX-32.2 dyn-ex32_2.htm EX-32.2 6219
9 GRAPHIC img108999187_0.jpg GRAPHIC 215689
10 GRAPHIC img108999187_1.jpg GRAPHIC 15301
11 GRAPHIC img108999187_2.jpg GRAPHIC 384603
12 GRAPHIC img108999187_3.jpg GRAPHIC 319508
13 GRAPHIC img108999187_4.jpg GRAPHIC 269848
14 GRAPHIC img108999187_5.jpg GRAPHIC 246579
15 GRAPHIC img108999187_6.jpg GRAPHIC 325042
  Complete submission text file 0000950170-25-028356.txt   15640900

Data Files

Seq Description Document Type Size
16 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT dyn-20241231.xsd EX-101.SCH 1348523
91 EXTRACTED XBRL INSTANCE DOCUMENT dyn-20241231_htm.xml XML 1857111
Mailing Address 1560 TRAPELO ROAD WALTHAM MA 02451
Business Address 1560 TRAPELO ROAD WALTHAM MA 02451 (781) 786-8230
Dyne Therapeutics, Inc. (Filer) CIK: 0001818794 (see all company filings)

EIN.: 364883909 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-39509 | Film No.: 25672995
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)